FDA recall D-0070-2023

Acella Pharmaceuticals, LLC · Class III · drug

Product

Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC 42192-614-30, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

Reason for recall

Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.

Distribution

Nationwide in the USA.

Key facts

Status
Terminated
Initiation date
2022-11-14
Report date
2022-11-30
Termination date
2024-08-21
Voluntary/Mandated
Voluntary: Firm initiated
Location
Alpharetta, GA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0070-2023